or
forgot password

Prognostic Value of Baseline CT Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection


N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Cancer

Thank you

Trial Information

Prognostic Value of Baseline CT Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection


Inclusion Criteria:



1. suspected and/or biopsy-proven pancreatic adenocarcinoma, and

2. referral to Radiology for pre-treatment baseline pancreatic protocol CT.

Exclusion criteria:

1) are absolute contraindications to intravenous iodinated contrast or CT scan.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Histological markers of tumor angiogenesis (microvessel density, EGF/VEGF expression level)

Outcome Time Frame:

1 day

Safety Issue:

No

Principal Investigator

Aya Kamaya

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

PANC0009

NCT ID:

NCT01326364

Start Date:

March 2010

Completion Date:

September 2015

Related Keywords:

  • Pancreatic Cancer
  • Pancreatic Neoplasms

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317